| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 |
|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||
Orthopedic product sales | |||||||||
64,516 | 71,814 | 82,513 | - | - | - | - | - | - | - |
Other revenue | |||||||||
166 | 389 | 99 | - | - | - | - | - | - | - |
Total Revenue | |||||||||
64,682 | 72,203 | 82,612 | - | - | - | - | - | - | 15,417 |
Orthopedic product sales | |||||||||
- | - | - | 89,388 | 58,194 | 34,569 | 32,563 | 32,414 | 29,657 | - |
Other revenue | |||||||||
- | - | - | 614 | 1,151 | 762 | - | - | - | - |
Royalties and other | |||||||||
- | - | - | - | - | - | 509 | 565 | 492 | 202 |
Total Revenue | |||||||||
- | - | - | 90,002 | 59,345 | 35,331 | 33,073 | 32,979 | 30,149 | 15,214 |
Cost of sales | |||||||||
22,166 | 28,717 | 32,511 | 27,710 | 20,262 | 13,034 | 14,185 | 10,337 | 9,109 | - |
Cost of tissue and medical devices sales | |||||||||
- | - | - | - | - | - | - | - | - | 3,363 |
Gross Profit | |||||||||
42,516 | 43,486 | 50,101 | 62,292 | 39,082 | 22,297 | 18,887 | 22,642 | 21,040 | 12,053 |
Operating Expenses | |||||||||
General and administrative | |||||||||
17,936 | 14,277 | 15,246 | 15,762 | 12,993 | 8,886 | 10,204 | 11,135 | 6,935 | 8,546 |
Sales and marketing | |||||||||
25,843 | 31,464 | 40,511 | 44,055 | 28,731 | 16,912 | 16,017 | 15,617 | 18,501 | 8,897 |
Research and development | |||||||||
932 | 1,702 | 2,441 | 3,410 | 2,546 | 1,443 | 572 | - | - | - |
Amortization | |||||||||
58 | 3,437 | - | - | - | - | - | - | - | - |
Impairment of goodwill and intangible assets | |||||||||
- | 48,146 | - | - | - | - | - | - | - | - |
Depreciation and amortization | |||||||||
- | - | 5,485 | 4,940 | 3,819 | 271 | 377 | 406 | 379 | 633 |
Extinguishment of debt | |||||||||
- | - | - | - | 2,345 | 0 | - | - | - | - |
Impairment of goodwill and intangible assets | |||||||||
- | - | 17,586 | 0 | 233 | 912 | 728 | - | - | - |
Acquisition and integration related expenses | |||||||||
- | - | - | 1,401 | 4,935 | 0 | - | - | - | - |
Restructuring expenses | |||||||||
- | 2,970 | 4,680 | 0 | - | - | - | - | - | - |
Separation related expenses | |||||||||
- | 1,568 | 1,901 | 0 | - | - | - | - | - | - |
Non-cash compensation expense | |||||||||
- | - | 85 | 266 | 246 | 135 | -5 | - | - | - |
Impairment of goodwill | |||||||||
- | - | - | - | - | - | - | 0 | - | - |
Non-cash consulting expense | |||||||||
- | - | - | - | - | - | - | 427 | 1,675 | - |
Non-cash consulting expense | |||||||||
- | - | - | - | - | - | - | - | 1,675 | - |
Non-cash consulting expense | |||||||||
- | - | - | - | - | - | - | - | - | 1,560 |
Other expense | |||||||||
- | - | - | - | - | - | - | - | - | 1,030 |
Total Operating Expenses | |||||||||
44,769 | 103,564 | 87,935 | 69,837 | 51,161 | 28,562 | 27,895 | 27,587 | 27,490 | 20,667 |
Loss from Operations | |||||||||
-2,253 | -60,078 | -37,834 | -7,545 | -12,078 | -6,264 | -9,007 | -4,944 | -6,450 | -8,614 |
Other (Expense) Income | |||||||||
Interest expense | |||||||||
5,772 | 10,145 | 14,705 | 12,262 | 7,733 | 5,660 | 4,653 | 1,864 | 1,162 | 1,646 |
Change in warrant derivative liability | |||||||||
3 | 121 | 203 | 716 | 270 | 1,736 | 875 | 1,360 | 6,377 | -9,206 |
Non-cash consideration associated with stock purchase agreement | |||||||||
- | - | - | - | 558 | 0 | - | - | - | - |
Write-off of debt related costs | |||||||||
- | - | - | - | - | - | - | 705 | 1,300 | - |
Other (expense) income | |||||||||
-101 | 3 | -75 | -351 | 388 | -318 | 92 | -1,558 | -471 | - |
Total Other (Expense) | |||||||||
-5,870 | -10,021 | -14,577 | -11,897 | -7,633 | -4,243 | -3,685 | -2,769 | 3,443 | -10,853 |
Net Loss Before Provision for Income Taxes | |||||||||
-8,123 | -70,099 | -52,411 | -19,443 | -19,711 | -10,507 | -12,693 | -7,713 | -3,006 | - |
Provision for Income Taxes | |||||||||
Net Loss Before (Provision) Benefit for Income Taxes | |||||||||
- | - | - | - | - | - | - | - | - | -19,467 |
Current | |||||||||
- | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred | |||||||||
- | - | - | - | -17,537 | 0 | 0 | 0 | 0 | 0 |
Provision for income taxes | |||||||||
-98 | - | - | 50 | - | - | - | - | - | - |
Net Loss | |||||||||
-8,221 | -70,099 | -52,411 | -19,493 | -2,174 | -10,507 | -12,693 | -7,713 | -3,006 | -19,467 |
Net loss per share: | |||||||||
Basic | |||||||||
-0.63 | -5.97 | -34.76 | -18.46 | -0.24 | -1.76 | -2.80 | -0.18 | -0.08 | -0.61 |
Dilutive | |||||||||
-0.63 | -5.97 | -34.76 | -18.46 | -0.24 | -1.76 | -2.80 | -0.18 | -0.08 | -0.61 |
Shares used in the computation: | |||||||||
Basic | |||||||||
13,163 | 11,740 | 1,507 | 1,055 | 9,055 | 5,954 | 4,530 | 42,445 | 38,944 | 32,178 |
Dilutive | |||||||||
13,163 | 11,740 | 1,507 | 1,055 | 9,055 | 5,954 | 4,530 | 42,445 | 38,944 | 32,178 |